Conference Coverage (Retrovirus)
Canarypox Prime/Boost Approach Ready for Advanced Trials
Published in Vaccine Weekly, February 10th, 1997
The approach employs priming immunizations with a recombinant canarypox virus (ALVAC, Virogenetics), dubbed vCP205, followed by boosting immunizations with recombinant HIV gp120 envelope glycoprotein (rgp120MN in MF59 adjuvant, Chiron/Biocine).
Lawrence Corey of the University of Washington, Seattle, and colleagues from the NIAID AIDS Vaccine Evaluation Group (AVEG) reported the latest findings from AVEG study 022 in a late-breaking news session at the Fourth Conference on Retroviruses and Opportunistic Infections, held January 22-26 in Washington,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1997-02-10)
More Articles from Vaccine Weekly
- Retrovirus Conference
AIDS Organizations Call for National Conference Expansion - Conference Coverage (Retrovirus)
Gene Types Linked to AIDS Progression - Conference Coverage (Retrovirus)
UNAIDS Chief: Only A Vaccine Can End AIDS - Associations
American Society of Gene Therapy Formed - HIV Vaccines (HGP-30)
Preclinical Data Presented on Potential AIDS Immunotherapy - Industry News (Patents and Technology)
European Patent Extension Lawsuit Decision Announced - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
